Trevi Therapeutics
TRVI
#4943
Rank
A$2.74 B
Marketcap
A$19.30
Share price
-1.81%
Change (1 day)
13.32%
Change (1 year)

Earnings for Trevi Therapeutics (TRVI)

Earnings in 2026 (TTM): -A$81.53 Million

According to Trevi Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$64.53 Million, an increase over its 2024 earnings that were of -A$68.22 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevi Therapeutics from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$81.53 Million26.36%
2025 -A$64.53 Million-5.42%
2024 -A$68.22 Million67%
2023 -A$40.86 Million2.43%
2022 -A$39.89 Million-14.45%
2021 -A$46.62 Million1.36%
2020 -A$46 Million23.64%
2019 -A$37.2 Million27.54%
2018 -A$29.17 Million